GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Total Debt/Equity History
[Consolidated]
Mar2025 | Mar2024 | |
---|---|---|
Total Debt/Equity(x) | 0.52 | 0.60 |
What is the latest Total Debt/Equity ratio of GUFIC BIOSCIENCES ?
Year | Total Debt/Equity |
---|---|
Mar2025 | 0.52 |
Mar2024 | 0.60 |
How is Total Debt/Equity of GUFIC BIOSCIENCES Trending?
Years | Total Debt/Equity | % Change | |
---|---|---|---|
Mar2025 | 0.52 | -13.33 | |
Mar2024 | 0.6 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Total Debt/Equity ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,503.0 Cr | -3.6% | -5.5% | -17.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,560.0 Cr | 2.2% | 2.1% | -10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,033.0 Cr | 0.3% | 6.4% | 8.7% | Stock Analytics | |
CIPLA | ₹134,400.0 Cr | 6.8% | 5.6% | 5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,507.0 Cr | 1.6% | -1.1% | 5.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,628.0 Cr | 4.6% | -2.5% | -4.3% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -3.6% |
-5.5% |
-17.3% |
SENSEX | 2.9% |
1.7% |
3.6% |
You may also like the below Video Courses